Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

P Soelberg Sorensen; Nils Koch-Henriksen; C Ross; K M Clemmesen; K Bendtzen; Danish Multiple Sclerosis Study Group

doi:10.1212/01.WNL.0000166049.51502.6A

Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

P Soelberg Sorensen, Nils Koch-Henriksen, C Ross, K M Clemmesen, K Bendtzen, Danish Multiple Sclerosis Study Group

185 Citations (Scopus)

Abstract

Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.

Original language	English
Journal	Neurology
Volume	65
Issue number	1
Pages (from-to)	33-9
Number of pages	7
DOIs	https://doi.org/10.1212/01.WNL.0000166049.51502.6A
Publication status	Published - 12 Jul 2005

Access to Document

10.1212/01.WNL.0000166049.51502.6A

Cite this

@article{a5f84b9ca94e4ca2ae8a06ebea571cbe,

title = "Appearance and disappearance of neutralizing antibodies during interferon-beta therapy",

abstract = "Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.",

author = "Sorensen, \{P Soelberg\} and Nils Koch-Henriksen and C Ross and Clemmesen, \{K M\} and K Bendtzen and \{Danish Multiple Sclerosis Study Group\}",

year = "2005",

month = jul,

day = "12",

doi = "10.1212/01.WNL.0000166049.51502.6A",

language = "English",

volume = "65",

pages = "33--9",

journal = "Neurology",

issn = "1526-632X",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

AU - Sorensen, P Soelberg

AU - Koch-Henriksen, Nils

AU - Ross, C

AU - Clemmesen, K M

AU - Bendtzen, K

AU - Danish Multiple Sclerosis Study Group

PY - 2005/7/12

Y1 - 2005/7/12

N2 - Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.

AB - Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.

UR - https://www.scopus.com/pages/publications/20444490479

U2 - 10.1212/01.WNL.0000166049.51502.6A

DO - 10.1212/01.WNL.0000166049.51502.6A

M3 - Journal article

C2 - 15888603

SN - 1526-632X

VL - 65

SP - 33

EP - 39

JO - Neurology

JF - Neurology

IS - 1

ER -

Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

Abstract

Access to Document

Other files and links

Fingerprint

Cite this